SEC
SlamSEC
Search
Browse
Earnings
IMPACT BIOMEDICAL INC. — SlamSEC
IMPACT BIOMEDICAL INC.
NYSE:
IBO
Pharmaceutical Preparations
·
HOUSTON, TX
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Summary Financials
Revenue
$50,000
FY 2023
Adj. EBITDA
-$2.9M
-5816.0% margin
FY 2024
Net Income
-$4.3M
-8672.0% margin
FY 2024
EPS (Diluted)
-$0.07
FY 2024
Stock Price
$0.67
+4.7%
2026-03-06
52W Range
$0.36 – $6.17
P/E Ratio
-9.6x
Market Cap
$70.3M
Cash
$1,000
FY 2024
Total Debt
$11.9M
FY 2024
Net Debt
$11.9M
FY 2024
Enterprise Value
$82.2M
Debt / EBITDA
-4.1x
FY 2023
EV / EBITDA
-28.3x
Employees
—